The Global Atherectomy Devices Market will reach US$ 2,028.3 Million by 2032, up from US$ 964.3 Million in 2023, with a CAGR of 8.61% between 2024 and 2032.
Atherectomy Devices Industry Overview
Atherectomy devices are medical instruments used to remove plaque from blood vessels.
Request a free sample copy of the report
Growth Drivers
- Rising Prevalence of Cardiovascular Diseases: The increasing incidence of cardiovascular diseases drives demand for effective treatment options.
- Advancements in Medical Technology: Innovations enhance device performance, safety, and efficacy.
- Growing Preference for Minimally Invasive Procedures: Patients and healthcare providers favor less invasive options due to benefits like reduced recovery time and lower risk of complications.
Europe Atherectomy Devices Market
The market is driven by factors like increasing incidence of peripheral artery disease and growing elderly population.
Leading Companies
- Boston Scientific Corporation, Inc.
- Abbott Laboratories
- Medtronic plc
- Cardinal Health
- Terumo Corporation
- Integer Holdings Corporation
- Becton, Dickinson and Company
- AngioDynamics Inc.
Recent Company News
- Cardinal Health debuted its SmartGown EDGE Breathable Surgical Gown in the US, enhancing surgical team safety and efficiency.
- The FDA approved Pantheris LV, Avinger’s next-generation image-guided atherectomy device, for treating peripheral artery disease.
- Abbott acquired Cardiovascular Systems, expanding its vascular device portfolio.
Related Reports
About Renub Research
Renub Research is a Market Research and Information Analysis company with over 15 years of experience.
Media Contact:
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Address: 225 Kristie Ln, Roswell, GA 30076
Email: info@renub.com
LinkedIn: https://linkedin.com/company/renub-research
Website: www.renub.com
